<SEC-DOCUMENT>0001640334-24-000007.txt : 20240104
<SEC-HEADER>0001640334-24-000007.hdr.sgml : 20240104
<ACCEPTANCE-DATETIME>20240104170745
ACCESSION NUMBER:		0001640334-24-000007
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240104
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240104
DATE AS OF CHANGE:		20240104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexaria Bioscience Corp.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39874
		FILM NUMBER:		24513132

	BUSINESS ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7
		BUSINESS PHONE:		250-765-6424

	MAIL ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXARIA CORP.
		DATE OF NAME CHANGE:	20080229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrp_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:lxrp="http://lxrp.com/20240104"><head><title>lxrp_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html" /></head><body style="text-align:justify;font:10pt times new roman"><div style='display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;' id='XBRLDIV'><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-01-04to2024-01-04">0001348362</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-01-04to2024-01-04" format="ixt:booleanfalse">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type='simple' xlink:href='lxrp-20240104.xsd'></link:schemaRef></ix:references><ix:resources><xbrli:context id="From2024-01-04to2024-01-04"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-04</xbrli:startDate><xbrli:endDate>2024-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"></td></tr><tr><td style="BORDER-BOTTOM: 2px solid;"></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:DocumentType">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (Date of earliest event reported) <strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen">January 4, 2024</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:74%;vertical-align:top;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityRegistrantName">LEXARIA BIOSCIENCE CORP.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td colspan="6" style="width:74%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityFileNumber">000-52138</ix:nonNumeric>&#160;</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityTaxIdentificationNumber">20-2000871</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">of incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission File Number)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Identification&#160;No.)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityAddressAddressLine1">100 &#8211; 740 McCurdy Road</ix:nonNumeric>, <ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityAddressCityOrTown">Kelowna</ix:nonNumeric>, <ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityAddressStateOrProvince">BC</ix:nonNumeric> <ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen">Canada</ix:nonNumeric> </strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityAddressPostalZipCode">V1X 2P7</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Registrant&#8217;s telephone number, including area code <strong><span style="text-decoration:underline">(<ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:CityAreaCode">250</ix:nonNumeric>) <ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:LocalPhoneNumber">765-6424</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Title of each class</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trading </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Symbol(s)</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name of each exchange on which registered</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Warrants to Purchase Common Stock</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:TradingSymbol">LEXX</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">LEXXW</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The Nasdaq Capital Market</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Emerging growth company&#160;<ix:nonNumeric contextRef="From2024-01-04to2024-01-04" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"></td></tr><tr><td style="BORDER-BOTTOM: 5px solid;"></td></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 7.01</strong>&#160;<strong>Regulation FD Disclosure</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 4, 2024, Lexaria Bioscience Corp. (&#8220;<strong>Lexaria</strong>&#8221;) announced the final results from its human pilot study (the &#8220;<strong>Study</strong>&#8221;) which evaluated a DehydraTECH&#8482; processed dosage of the glucagon-like peptide-1 (&#8220;<strong>GLP-1</strong>&#8221;) drug semaglutide found in Rybelsus&#174; against a parallel dosage of non-DehydraTECH processed Rybelsus&#174;.&#160; The Study was conducted in a university research center as a cross-over design over two study visits, one in November and the second in December, whereby all seven healthy subjects were dosed with each test article.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Results from the Study indicate at all 19 blood point sample time points, that the DehydraTECH GLP-1 blood semaglutide level was higher than the Rybelsus&#174; control sample and that peak levels of semaglutide in blood were 43% higher in the DehydraTECH GLP-1 than in the Rybelsus&#174; control sample.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">Additional results indicated that:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">subjects receiving the DehydraTECH GLP-1 processed semaglutide did not experience the side effects of moderate nausea and moderate diarrhea that the subjects taking the Rybelsus&#174; control sample experienced</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">DehydraTECH GLP-1 reduced blood glucose to lower levels than the Rybelsus&#174; control sample and was much more effective at maintaining consistently reduced blood glucose levels even after eating a standardized meal at the 240-minute mark and a standardized snack at the 360-minute mark</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01</strong>&#160;<strong>Financial Statements and Exhibits</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:6%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="lxrp_ex991.htm">99.1</a></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="lxrp_ex991.htm">Press Release dated January 4, 2024</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>LEXARIA BIOSCIENCE </strong><strong>CORP.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Chris Bunka</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Chris Bunka</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">CEO, Principal Executive Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:5%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date:</p></td><td style="width:30%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">January 4, 2024</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lxrp_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>lxrp_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lexaria&#8217;s Patented Technology Improved the Oral Performance of the Rybelsus&#174;-Branded GLP-1 drug Semaglutide</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Final results from a human pilot study show DehydraTECH<sup style="vertical-align:super">TM</sup></em><em>-powered semaglutide outperforms Rybelsus</em><strong><em>&#174;</em></strong><em>:</em> </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Sustained higher levels of semaglutide in blood;</em></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Better blood glucose control;</em></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Faster achievement of peak drug delivery; and</em></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Reduced side effects.</em></p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Kelowna, British Columbia &#8211; January 4, 2024</strong> &#8211; Lexaria Bioscience Corp. (Nasdaq: LEXX &amp; LEXXW) (the &#8220;Company&#8221; or &#8220;Lexaria&#8221;), a global innovator in drug delivery platforms announces positive final results from its recently completed human Pilot Study #1 (the &#8220;<strong>Study</strong>&#8221;) evaluating DehydraTECH<sup style="vertical-align:super">TM</sup> technology for the <em>oral</em> delivery of the glucagon-like peptide-1 (&#8220;<strong>GLP-1</strong>&#8221;) drug semaglutide available commercially in the branded product Rybelsus&#174;.&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Study was performed by a prominent university research center comparing a single 7 mg semaglutide dose of a Rybelsus&#174; tablet (&#8220;<strong>Control</strong>&#8221;) to a matching dose from Rybelsus that had been compound formulated in capsule form using DehydraTECH processing technology enhancements (&#8220;<strong>DehydraTECH GLP-1</strong>&#8221;).&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In general, the DehydraTECH processing enabled improvements in delivery of semaglutide to the bloodstream, and the improvements in controlling blood sugar were more pronounced in the final combined results of the Study than they were in the first half of the Study as reported in press releases issued <u><font style="color:blue">November 27</font></u> and <u><font style="color:blue">November 28</font></u>, 2023.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Blood Levels of Semaglutide</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The first post-baseline blood was sampled 20 minutes after oral administration and, at that point in time, the DehydraTECH GLP-1 blood semaglutide level was ~261% higher than that of the Control, demonstrating DehydraTECH&#8217;s well-known ability to deliver drugs to the bloodstream faster. At each of the 19 blood sample time points, the DehydraTECH GLP-1 blood semaglutide levels were higher than the Control levels.&nbsp; The peak levels of semaglutide in blood were 43% higher in the DehydraTECH GLP-1 than in the Rybelsus&#174; Control.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Blood Semaglutide Levels (mmol/L)</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="lxrp_ex991img1.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Rybelsus Control <font style="color:#4f81bd">(blue</font>) 7mg (n=7)&nbsp;&nbsp;&nbsp; DehydraTECH (<font style="color:#c0504d">orange</font>) GLP-1 7mg (n=7)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">24 hours after the ingestion of the single dose, the DehydraTECH GLP-1 blood semaglutide levels were approximately 44% higher than the Control levels (Note - only the first 10 hours post dosing is shown in the graph above).&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Side Effects</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The DehydraTECH GLP-1 processed semaglutide was generally better tolerated than the Rybelsus&#174; tablets themselves. Only the Rybelsus&#174; tablets resulted in instances of moderate nausea and moderate diarrhea, whereas no such instances were reported upon DehydraTECH-semaglutide dosing.&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Blood Glucose Levels</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">It is accepted by the Food and Drug Administration (&#8220;<strong>FDA</strong>&#8221;) that, &#8220;<em><u><font style="color:blue">one role of GLP-1</font></u></em><em> is to prompt the body to produce more insulin, which reduces blood glucose (sugar)</em>.&#8221; Because blood glucose levels are a key consideration in control of diabetes and other health conditions, the Study measured blood glucose levels at each of the 19 sample time points.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Blood Glucose Levels (mmol/L)</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="lxrp_ex991img2.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Rybelsus Control &nbsp;<font style="color:#4f81bd">(blue</font>) 7mg (n=7)&nbsp;&nbsp;&nbsp; DehydraTECH (<font style="color:#c0504d">orange</font>) GLP-1 7mg (n=7)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Control group evidenced inconsistent blood glucose reduction that did not prevent blood glucose spikes after eating. DehydraTECH GLP-1 reduced blood glucose to lower levels and was much more effective at maintaining consistently reduced blood glucose levels even after eating a standardized meal at the 240-minute mark and a standardized snack at the 360-minute mark. Actual data levels for each hour after Rybelsus&#174; (control) and DehydraTECH drug administration are shown below.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Blood Glucose Levels (mmol/L)</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:16%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Minutes</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:20%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Control Mean</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:20%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Change from Time Zero</p></td> <td style="width:1%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="width:20%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">DehydraTECH Mean</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:20%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Change from Time Zero</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.04</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.13</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">60</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.84</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-3.97%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.54</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-11.42%</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">120</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.63</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-8.22%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.34</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-15.32%</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">180</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.49</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-11.05%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.33</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-15.60%</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">240</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.46</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-11.61%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.33</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-15.60%</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">300</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.43</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>+</strong>7.65%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.60</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-10.31%</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">360</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.39</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>+</strong>6.80%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.64</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-9.47%</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">420</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.5</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>+</strong>9.07%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.67</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-8.91%</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">480</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.3</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>+</strong>5.10%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.64</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-9.47%</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">540</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.09</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>+</strong>0.85%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.60</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-10.31%</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">600</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.03</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-0.28%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.61</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-10.03%</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24-Hour</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5.04</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.87</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-5.01%</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Notably, even as long as 24 hours after dose administration, the blood glucose levels were reduced in the DehydraTECH GLP-1 group by 5.01% relative to baseline while the blood glucose levels evidenced in the Rybelsus&#174; Control group were unchanged. Our current assumption is that the improved delivery of semaglutide using DehydraTECH is most likely responsible for the observed greater efficacy in achieving sustained blood glucose reduction, thereby helping to attenuate the postprandial spikes in blood glucose experienced in the Control group. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This Study is only meant to provide early-stage indicative information to Lexaria about the possibility of enhancing the pharmacokinetic and pharmacodynamic performance of orally delivered GLP-1 drugs to assist in guiding the Lexaria team in additional investigations. There was minor variability in the diets of the subjects at the 240-minute meal and 360-minute snack intervals noted above during the concentrated 10-hour post dosing monitoring period which could account for some of the differences in the test data, although meal and snack selection allowance was from a set of standardized choices.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Future Work</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the success of the Study, Lexaria is already preparing for other human and animal studies to continue the evaluation of DehydraTECH&#8217;s effectiveness with GLP-1 drugs. This work will be conducted on an expedited basis given the urgent need for effective oral delivery of GLP-1 drugs and DehydraTECH&#8217;s apparent ability to improve their performance. Lexaria will provide more details about its GLP-1 strategy in separate news.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About the Study</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Study was performed to provide an early-stage indication of whether DehydraTECH processing could improve <em>oral</em> drug delivery characteristics of the GLP-1 drug semaglutide sold as Rybelsus&#174;.&nbsp; A single semaglutide dose of 7 mg of the Control was compared to the matching dose of the DehydraTECH GLP-1, swallowed by each subject after an overnight fasting period together with a 50 mL glass of water. The DehydraTECH GLP-1 formulation used in this Study was compound formulated strictly for research purposes. Seven healthy subjects were dosed with each test article following a cross over study design across two study visits. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><u>About Semaglutide</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Rybelsus&#174; (semaglutide) is <u><font style="color:blue">the only GLP-1 drug approved by the FDA</font></u> <em>for oral dosing</em> to treat diabetes and weight loss. The FDA has also approved semaglutide marketed as Ozempic&#174; and Wegovy&#174;, <em>administered by injection</em>, to treat diabetes and weight loss. All three of these drugs are owned and manufactured by Novo Nordisk&#174;.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About Lexaria Bioscience Corp.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lexaria Bioscience Corp.&#8217;s patented drug delivery technology, DehydraTECH&#8482;, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 38 patents granted and many patents pending worldwide. For more information, please visit <u><font style="color:blue">www.lexariabioscience.com</font></u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the Company&#8217;s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements.&nbsp; As such, you should not place undue reliance on these forward-looking statements.&nbsp; Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company&#8217;s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&amp;D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria&#8217;s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA).&nbsp; Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>INVESTOR CONTACT:</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>George Jurcic - Head of Investor Relations </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u><font style="color:blue">ir@lexariabioscience.com</font></u> </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Phone: 250-765-6424, ext 202</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrp-20240104.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/04/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:lxrp="http://lxrp.com/20240104" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://lxrp.com/20240104">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://lxrp.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240104_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240104_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240104_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240104_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
 <import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
 <import namespace="http://fasb.org/srt-roles/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd" />
 <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
 <import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
 <import namespace="http://fasb.org/us-roles/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd" />
 <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
 <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
 <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lxrp-20240104_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/04/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address Country</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>lxrp-20240104_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/04/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240104.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lxrp-20240104_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/04/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240104.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lxrp-20240104_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/04/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240104.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>lxrp_ex991img1.jpg
<TEXT>
begin 644 lxrp_ex991img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #[ <X# 2(  A$! Q$!_\0
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M_P#?L59HH K?8K/_ )]8?^_8K-UJWMX;)&2WC!,@'RJ!Q@UMUDZ[_P >,?\
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M?]Z;_O\ O_C5BB@"O]DC_O3?]_W_ ,:/LD?]Z;_O^_\ C5BB@"O]DC_O3?\
M?]_\:@FMT66W56FP\A5OWS]-K'U]0*OU7N/^/BT_ZZG_ - :@ ^R1_WIO^_[
M_P"-'V2/^]-_W_?_ !JQ10!7^R1_WIO^_P"_^-'V2/\ O3?]_P!_\:L44 5_
MLD?]Z;_O^_\ C1]DC_O3?]_W_P :L44 5_LD?]Z;_O\ O_C1]DC_ +TW_?\
M?_&K%% &?;VZ21,S/-GS'7_7/T#$#OZ"K'V2/^]-_P!_W_QHM/\ 4M_UUD_]
M#-6* *_V2/\ O3?]_P!_\:/LD?\ >F_[_O\ XU8HH K_ &2/^]-_W_?_ !H^
MR1_WIO\ O^_^-6** *_V2/\ O3?]_P!_\:/LD?\ >F_[_O\ XU8HH H36Z++
M;JK38>0JW[Y^FUCZ^H%3_9(_[TW_ '_?_&BX_P"/BT_ZZG_T!JL4 5_LD?\
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M[_XU8HH K_9(_P"]-_W_ '_QH^R1_P!Z;_O^_P#C5BB@"O\ 9(_[TW_?]_\
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M'J#76V?_ "#X/^N2_P JRM<UR;0[=[DZ+?7]M'&TLLMJT $07DY$DB$\>@-
M%2_L=>=M.O+5+&YN]/D('GSM$MRC1;68E8SY;;N0 &&!U&>-+0["32]%M;.>
M19)HU)D9!A2Y)9L9YQDG'M46HZP;"WM)1I]U=7-VVV&RA">:3M+'.YE48 .2
M6QV&21FWIM]!JNF6VHPAUCG0.%D7:R^JL.Q!X(]10 FH)YESIRDL,W!^ZQ4_
MZJ3N*M?9(_[TW_?]_P#&H;S_ (_--_Z^#_Z*DJ]0!7^R1_WIO^_[_P"-'V2/
M^]-_W_?_ !JQ10!7^R1_WIO^_P"_^-'V2/\ O3?]_P!_\:L44 5_LD?]Z;_O
M^_\ C1]DC_O3?]_W_P :L5#)(D2-)(0BJ"S,3@ #N: .'^)C6]K\/=17[9-;
M33J(8=KNS2N6'[L#/.X @^V37&_"OX?ZMI>KSZUK=JMOB)H88MX+[BPR^5/R
MX *^O)KH]%C?QWXK_P"$FN4(T/3G:/3(F'$S@X:<CZCCZ>H->A6G^J;_ *Z2
M?^AFL5!2ES/IL=_MY4*3HQWEOY>7^8_[)'_>F_[_ +_XT?9(_P"]-_W_ '_Q
MJQ16QP%?[)'_ 'IO^_[_ .-'V2/^]-_W_?\ QJQ10!7^R1_WIO\ O^_^-'V2
M/^]-_P!_W_QJQ10!7^R1_P!Z;_O^_P#C4$UK&)K8;I>9".9G_N-[U?JO<?Z^
MT_ZZG_T!J #[)'_>F_[_ +_XT?9(_P"]-_W_ '_QJQ10!G7&F6=U;R0W$;3P
MR+M>.21F5AZ$$X(J.QT73=.M1:V%K]D@4DB*!F103UX!Q6G2]J!W=K="O]CA
M_O3?]_G_ ,:/L,'_ $U_[_/_ (U9HH$9TNEV4R[9HFD&,8>1FX_$UAZOX%\.
MZQ83VLFG11-*NWS8UPZ'L0?:NKI#2:3W-(U)P:<78\G\,_!WP_8Q7#ZQ(=8=
MV*+N0PK&%8C@*Q.3CKFN@_X57X0C'^AVUW8GU@O)1_-C78VO^I;_ *ZR?^AF
MIZA0BE:QI/%5IRYG)_><(?AUM;=:>,O$L'M]NW+^1%,/@[QA#C['\1;U<=KB
MV27/ZBN]PW]ZG8JN5"5>HNJ?JD_T/*];L_B3I.A7-U:ZU;:F8HR?EAD6;'<J
M V"1UP?2N0^'>O?$/5)+S[,?[7MTP6>_N)$"M_=5@>I]#QQV[_0.SBD"8Z#%
M9.F^9/F9T1Q:5.4)03;ZVM^1P'V_XB1K\_A.VG)_YYZJRX_.D_MSQTA*R?#V
M<H.KIK2MGZ#K7H>:7BKY7_,_P.?VL7O!?C_F>;2>)O$2/#Y_@/4U;><!+T29
M^4]\\'_"DF\<7L-O*[>!_$FY%/1689^H;IGOZ<UZ#<?Z^UX_Y:G_ - :I^/[
MHHY9=RO:T_Y%][_S/GOPG\5M0;Q \?BB;&F2;B7C\P?9CR1]TDD9P.<GD'/6
MO8M,U[PQK# :9KT5PYZ1K>-O_P"^2V?TK1MM&TBQGGN+/2[6WFN#F62*%4:3
M_>('/XUF:EX(\)ZKN^VZ!9NS=72/RW/_  )<']:F$9Q5KW-:M2A4E>,7'TL_
MPT_,V_LT7_/28_\ ;=_\:=]EC_O3?]_G_P :XG_A7:V1W>'?$VL:1C[L2W'G
M0C_@#]?SI#;_ !0TMAY.HZ5KL0ZFXA:WE;Z;/E_.KNUNC#V49?#)?/3^OO.W
M^S1?WIO^_P _^-+]EB/\<W_?Y_\ &N'_ .$VU[3U_P")WX$U*W ZR6;+=(/?
MY<8%<=8_'!)/$QAOM/6WT9F*+,-QFC'9V X/N ,C/?'(YQ6[-(X2K--Q5[=F
MG^1[3]DB_O3?]_G_ ,:K6UK&T39:7_62#B9Q_&?>N3_X6EX7;Y8/M]PW]V.S
MD)QZ\BHK?XE::L9$.@Z]< NY#1:>Q!RQ..O6CG7<S]A4[,[G[+'_ 'I?^_S_
M .-+]EC_ +\W_?Y_\:XA?B)<2'$/@3Q,Q_Z:60C'YEJ=_P )OKLG_'OX U9L
M_=\UDC_/)XI\Z%[";_X='9?98_[\Q_[;/_C2_9H_[TW_ '^?_&O!M4^*_C*U
M\;?9?[+6VCBD6)M,90\DGK\X&<G/&..G![^B_P#"PI8>+KP7XCB/=ELQ(@_$
M-4QG&5S:K@ZE-1;2=^S1VWV6+^]-_P!_G_QH^RQ_WIO^_P"_^-<:?BEX3A!^
MW27UACK]IL95Q^2FKEO\1O!-Q]SQ%:+_ -=&,?\ Z$!3YH]S!T:BWB_N.F^R
MQ_WIO^_S_P"-1"%8[Z+:S_ZM_O.S=U]35*W\2>'[H#[+KEA/G_GG<(W\C5";
MQ9X<M_$UOI,VKVXO70JL6[^)BNT$] 3C@$YZ>HIW7<E4YO:+^XZJLG7?^/&/
M_KH/Y&M;M63KO_'C'_UT'\C5$%VS_P"0?!_UR7^59VL:?<:E]CM4D1;07*2W
M08G<Z)\RJN/5PF<]L^M:-G_R#X/^N2_RK,U;6&TZ>WM8=/N]2O+C<R6]KY8;
M8N-SDR.B@ LHZYR1@'F@"MJMIK4U[:7VGVUD\UC.QCCGN719HVCVMEA&=C!C
MP,,"!VSQ>T.PDTO1;6SGD62:-29&084N26;&><9)Q[4S5M6_LM+8)I]U>W-T
M^R*VMBGF,0I8\NRJ  #DEAV R2!5G3;Z#5=,MM1A#K'.@<+(NUE]58=B#P1Z
MB@!-03S+G3E)89N#]UBI_P!5)W%6OLD?]Z;_ +_O_C4-Y_Q^:;_U\'_T5)5Z
M@"O]DC_O3?\ ?]_\:/LD?]Z;_O\ O_C5BB@"O]DC_O3?]_W_ ,:/LD?]Z;_O
M^_\ C5BB@"HUM&%)W3?]_G_QKY^U#XA7GB[78_"\2R6.EW]TEJTBR.\SQEMI
M!RVT;N_''3GO]!S2QPP232N$C12S$] !R37F_P /O#VG7T]WXYNM-C6ZO[F6
M:TRI!BASA?EZ;C@G.,\^]934I-*+.["RIPC.517:V]3OK'2;.QLH;.UC>&"%
M D<:2N JCH.M/M;6-H6):7_62#B9Q_&?>K]5[3_4M_UUD_\ 0S6IQ-MZL7[)
M'_>F_P"_[_XT?9(_[TW_ '_?_&K%% BO]DC_ +TW_?\ ?_&C[)'_ 'IO^_[_
M .-6*3.!D\"@"O\ 98_[TW_?Y_\ &E^RQ_WIO^_S_P"-8^E^*M UN\GL]+U2
M&ZN(.71">F<9']X>XR*M:QK6EZ'8F\U6]CM(,A0[]R>P Y)^E/EDG:VI'/%K
MFOH7OLL?]Z;_ +_/_C5>:UC\VV&Z7F0CF9_[C>]+I^H6>J6,5]I]REQ;RC*2
M(<@_Y]*GN/\ 7VG_ %U/_H#4FFG9E)WU0?9(_P"]-_W_ '_QH^R1_P!Z;_O^
M_P#C5BB@97^R1?WIO^_S_P"-)]DC_O3?]_W_ ,:AO]2LM+L9;[4+A(+:(;GD
M<X JOI&MZ7KE@+K2KV.[@W%2R9X([$'D?C3Y96O;0GF5^6^I?^R1_P!Z;_O^
M_P#C1]DC_O3?]_W_ ,:GS2YI%%?[)'_>F_[_ +_XT?9(_P"]-_W_ '_QJQ10
M!GVMK&T+$M+_ *R0<3./XS[U8^R1_P!Z;_O^_P#C1:?ZEO\ KK)_Z&:L4 5_
MLD?]Z;_O^_\ C1]DC_O3?]_W_P :L44 5_LD?]Z;_O\ O_C1]DC_ +TW_?\
M?_&K%% %?[)'_>F_[_O_ (T?9(_[TW_?]_\ &K%% %":UC$UL-TO,A',S_W&
M]ZG^R1_WIO\ O^_^-%Q_Q\6G_74_^@-5B@"O]DC_ +TW_?\ ?_&C[)'_ 'IO
M^_[_ .-6** *_P!DC_O3?]_W_P :/LD?]Z;_ +_O_C5BB@"I]ECQRTW_ '^?
M_&N=A\"^&;777UR'35COW8L91))G)ZD#=@'W KJ_XJ.])I/<J,YPORNURO\
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MS3?^O@_^BI*O4 5_LD?]Z;_O^_\ C1]DC_O3?]_W_P :L44 5_LD?]Z;_O\
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MC.(&@5#)[!\_*<9_''3K7IM%4JTT[Z?<B'1BU;7[V>"_#_0?B%B\-O>3Z1;
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M+\4H>G[J)I1[\A^E._X3[047_2K'7+,=<S6\PP/7@FN]HK+FCUC^)KRS_F_
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M_/[-^2?_ !-'D2_\_LWY)_\ $U/10!7^SR_\_DWY)_\ $TOD2_\ /Y-^2?\
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M'_7)?Y5SOBC1[W68(K>UTW3+K"MLN;R1DELI#C;+$51B6'7@H<@?,.W16?\
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M-"\0:W0@YD D=58CL,]3D\#%<V^CZE'!-INF^'[B"ROK>UA1I)H?]"$9(82
M.23MP1LW9)P<=:]&HH XC1M/UB/5=/M+K2Y+:VTM[EOM;2QLESO8A-BJQ8?*
MV3N"X(P-W6NWHHH **** "BBB@ KSO4M%UC4;[4IK32;NT9K>9&-[>+-'<ON
M4QB'YV,2G:<\1CE<JV!M]$HH \_:UUPZZOBK_A'KO(F"?V?Y\'G^7Y)7?GS/
M+^\?N[^G/7Y:Z?P[97&G^'[2UO(U2X"EY$5MP1F8L5SWQG&>^*V:* "BBB@
MHHHH *YOQ+I>J:I!;#3[ZVM_(9I#%<VIG65MI"])$P03D<GG![5TE% 'FRZ/
MXDALFTJ;31<OJ%K:127<+)'%;&,X<.K.6.%QC;NW'/W1S6EHVGZQ'JNGVEUI
M<EM;:6]RWVMI8V2YWL0FQ58L/E;)W!<$8&[K7;T4 %%%% !1110 4444 >;W
MFBZM=3ZHFEZ3J.G6\L,[R1WU^LD5U,SAT\I!)((\D/DX3[_0]K#6NN'75\5?
M\(]=Y$P3^S_/@\_R_)*[\^9Y?WC]W?TYZ_+7H%% &-X=LKC3_#]I:WD:I<!2
M\B*VX(S,6*Y[XSC/?%;-%% !1110 4444 <GXNTRXU :5-#9WEY':7+2206-
MX;69@8G0%7WIT+#(W#C/7H<"/1O$D=G+IMQ8373ZG;VR27C7*,+8HQW"4LVY
MR$QAE#;CG..M>ET4 <1HVGZQ'JNGVEUI<EM;:6]RWVMI8V2YWL0FQ58L/E;)
MW!<$8&[K70Z[_P >,?\ UT'\C6M63KO_ !XQ_P#70?R- %VS_P"0?!_UR7^5
M6:K6?_(/@_ZY+_*K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%4;ZQM-2LI+._LX;NVDQOAGC$B-@Y&5/!Y ->?>#_#
M'AL>,?%KCP[I@:RU*+[*?LD>8/W$;?)Q\OS<\8YYH ]#M;NUOK5;JRNH[F!L
M[987#JV#@X(XZ@BKE>6:3XJU9M(\)6^CZ;I%G)K5Q=PL@A9(8!'O.Y54\GY<
MD9^8\97.1;_X23QE]G\2+Y>D&;P\Q+R^5)MO1Y8E"JF_]T=I W%GY/2@#TBB
MO.]4\>QKJ&FV%KJVD:&;FP34)+C5SE0K\)&B^9'N;J2=W '0YXZ+PCKR^)/#
M5MJS+$)&9XI/)??&71RC,A[J2N0?0B@#8^TV_P!K^Q^<GVG9YGD[AOVYQNQU
MQGC-6JX'2;N7[?X[\0[%:XMK@VL(<9 2"$,!QS@N[G\:S[?Q/XRDT[PQJ4EO
MI$D7B#9$MNBRH;9GB+B0R%CO&%8E-@[#<?O$ ]"NKRUL;1[J\N8K:!,;I9G"
M(O..2>!S5RO,=:\3:E;^&_%EGJ]EIVH7>C/;\M;M]FN4EVE28F=B".?XCR ?
M:MJ;5_$U]XOU70]'_LRWBL;6"?[1=122EFDW_)L5UX.W[V>,=&SP =1)=6T5
MS#;37$<<\V[RHF8!I,#)VCJ<#KBKE>8:UKDFJ?#OP]XN\E8+RVO[:8HIR%8R
M^3(H/H0SBO3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ K)UW_ (\8_P#KH/Y&M:LG7?\ CQC_ .N@_D: +MG_ ,@^#_KDO\JL
MUQ4.L:BJ*BW&%"# V+Q^E2_VUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%'
M]M:E_P _/_CB_P"% '845Q_]M:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?
M_;6I?\_/_CB_X4?VUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%']M:E_P _
M/_CB_P"% '845Q_]M:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?_;6I?\_/
M_CB_X4?VUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%']M:E_P _/_CB_P"%
M '845Q_]M:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?_;6I?\_/_CB_X4?V
MUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%']M:E_P _/_CB_P"% '845Q_]
MM:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%8&CZ&=*U;6]0^U>=_:MRMQL\O;Y
M6(U3&<G=]W.>.M9W]M:E_P _/_CB_P"%']M:E_S\_P#CB_X4 5]+\"G38_#"
M_P!J>;_84US-_J-OG^:'&/O?+C?[YQVK2_X1DY\3_P"G?\A[_IE_J/W(B]?F
MZ9[>GO57^VM2_P"?G_QQ?\*/[:U+_GY_\<7_  H %\*WUG/IU]HNJ1VM];6,
M>GS-<6IFBN(T^Z2@="K DD$-T)!!XQT5G%<P6T<=Y=&[G )>;RP@8DYX4= .
M@')P!DD\GG?[:U+_ )^?_'%_PH_MK4O^?G_QQ?\ "@"O8:3=0Z[XMTAX7BLM
M7 O(+E8R4#21^5(I/3<"@;&>0U6XO"?EZ3X5L/MY/_"/O$^_RO\ CXV0M'TW
M?+G=GOTQ3/[:U+_GY_\ '%_PH_MK4O\ GY_\<7_"@!NL^"3JT?B5/[2\G^W!
M;C/D[O(\K'^T-V<>V/>M:ST5K3Q1JFN?:M_V^&"'R=F/+\K?SG/.=_H,8[UE
M_P!M:E_S\_\ CB_X4?VUJ7_/S_XXO^% &3?^&KFV\,^'?!</G7L1U!9;FY6$
MJB11R&8[NH&2%4 GG->C5Q_]M:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?
M_;6I?\_/_CB_X4?VUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%']M:E_P _
M/_CB_P"% '845Q_]M:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?_;6I?\_/
M_CB_X4?VUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%']M:E_P _/_CB_P"%
M '845Q_]M:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?_;6I?\_/_CB_X4?V
MUJ7_ #\_^.+_ (4 =A17'_VUJ7_/S_XXO^%']M:E_P _/_CB_P"% '845Q_]
MM:E_S\_^.+_A1_;6I?\ /S_XXO\ A0!V%%<?_;6I?\_/_CB_X4?VUJ7_ #\_
M^.+_ (4 =A63KO\ QXQ_]=!_(UB_VUJ7_/S_ ..+_A4=UJ5\\"[YL_-_='^%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>lxrp_ex991img2.jpg
<TEXT>
begin 644 lxrp_ex991img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" $Z >D# 2(  A$! Q$!_\0
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M2:(*Z@EHV+H KA06V'#;><8.:E706%E/#)>>9<7&H+?23>5C=ME5U3&>R(J
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M07QZ8Z9S5C1?"-CI%MIZ_;-1GGLX8X]W]H7"PN54+GR?,* ''3&*9>:%=?\
M"-ZI8QR?:KK59W,TNT)A9&"YP3T2/ '.3L'KB@#K**0< "EH **** "BBB@
MHHHH *X*N]K@J .TL_\ D'P?]<E_E5FJUG_R#X/^N2_RKGX/$K7'C2[T%1IB
M"V8!E;4,73CRU?<L'E\K\V,[^Q^E '4T5R>J>++>P\3VV@Q2::MS(L;R"]U
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M )_9OR3_ .)H\B7_ )_9OR3_ .)H GHJ#R)?^?V;\D_^)H\B7_G]F_)/_B:
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M_P"_)_\ BJ-MY_S\1?\ ?D__ !56** *^V\_Y^(O^_)_^*HVWG_/Q%_WY/\
M\55BB@"OMO/^?B+_ +\G_P"*HVWG_/Q%_P!^3_\ %58HH K[;S_GXB_[\G_X
MJC;>?\_$7_?D_P#Q56** *$*W?G7.)H@?,&<Q'GY%_VJGVWG_/Q%_P!^3_\
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M_OR?_BJL44 5]EY_S\1?]^3_ /%4;;S_ )^(O^_)_P#BJL44 5]MY_S\1?\
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MM]4G>2XM+I[<1RY\R%0%^1L\Y!)Z]L#M7HG:O/)I&\,_$F*Z^SRQZ=X@40R
MLN%NE^Z>N!N''N<UW?GR?\^<WYI_\56-7WI<RV>I=/2/*]UH6J*@\^7_ )\Y
MOS3_ .*H\^7_ )\YOS3_ .*K,V)ZKV__ !\7?_74?^@+2^?+_P ^<WYI_P#%
M57AFD$US_H<IS(. 4X^1?]J@"_14'GR_\^<WYI_\51Y\O_/G-^:?_%4 3T5!
MY\O_ #YS?FG_ ,51Y\O_ #YS?FG_ ,50!/14'GR_\^<WYI_\51Y\O_/G-^:?
M_%4 3T5!Y\O_ #YS?FG_ ,51Y\O_ #YS?FG_ ,50 EO_ ,?%W_UU'_H"U8JA
M#-()KG_0Y3F0< IQ\B_[56//E_Y\YOS3_P"*H GHJ#SY?^?.;\T_^*H\^7_G
MSF_-/_BJ )Z*@\^7_GSF_-/_ (JCSY?^?.;\T_\ BJ ).]<'X+SK'B'Q!XL;
MYH[FX^QVA_Z8Q<9'LQY^HK0\;:Y/I/@V^N(;>5+J9?L]ORN?,?Y1C!/(R3^%
M7O#FGMH?AG3])CLI?]&A"L04PS]6/WN[$FM(^[%OOH8OWII=M3H:KV__ !\7
M?_74?^@+2^?+_P ^<WYI_P#%57AFD$US_H<IS(. 4X^1?]JLS8OT5!Y\O_/G
M-^:?_%4>?+_SYS?FG_Q5 $]%0>?+_P ^<WYI_P#%4>?+_P ^<WYI_P#%4 3T
M5!Y\O_/G-^:?_%4>?+_SYS?FG_Q5 $]%0>?+_P ^<WYI_P#%4>?+_P ^<WYI
M_P#%4 ):?ZEO^NLG_H9JQ6?:S2"%L6<K?O).04_OG_:JSY\O_/G-^:?_ !5
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M#- %BBBB@ HHHH **** "BBB@"O:?ZEO^NLG_H9JQ5>T_P!2W_763_T,U8H
M*X*N]K@J .TL_P#D'P?]<E_E7&OXPM9O']OI,.OV44,<SV<EF98_-FEV%LD'
MY@ =JC&,G=UXKLK/_D'P?]<E_E3;BTM[B:">1=TD!8QL&(VDJ5/3V)H XOQ+
MK6K6?BN"WLKR[CME$!=H((Y+:+=(0_VEF4NH*XV[".Y.!S7?US\WA31+FXAG
MN(;F1XU13NO)L2A#E?-&_$N#_?W5T% &7;SI'>ZBK+)GSP?EC9A_JH_05<^U
M1_W9O^_#_P"%0V?_ !^:E_U\#_T5'5Z@#D?&FFKX@\*7=C LRW8436SB)P4F
M3YD(...1C/O4WA7Q)%KGA>RU!E<3NFV=5B8[)5X<<#U!KI?:O/=%QX;^)FI:
M&WR66M W]IZ"4<3(/<XW?05GM)/N=$??IN/5:K]3O?M,?]V;_OR_^%>8?$7P
M/=>+KZTU#3KGR9X8_)>.XBE"%<D@@A#SD^GIZ5ZK16].<J<N:.YQU*<:D>66
MQRWA/1[/PSX;M=)A\R21 3)*+=E,C$DDGCWP,]L5T7VJ'^Y+_P!^'_PJ>DSP
M:AR<I.4MV5&*BE%'#^*O#>FZM:7&IVMG<V^NPQL]M=6BO%*9 OR@L!R"<#GM
MZ5YQ\/?%WB5O'J:9JVH3SPW1D6>*X!+(ZH2-HZ@Y4# [?2OH#J:X_P 4:!)K
MFDW8LW\K4[*X6YLI1P5E5%('T/3\O2NBG57*X35[[/L<]2D^93B[6Z=SJOM<
M?]V;_OR_^%'VN+^[-_WY?_"L;PQKT?B+P_!J"IY4W,<\)X,4J\,I_']"*W^]
M<[3BW%[HZ8M25T0_:X_[LW_?A_\ "C[7'_=F_P"_#_X58HH&5_M<?]V;_OP_
M^%'VN/\ NS?]^'_PJQ10!7^UQ_W9O^_#_P"%'VN/^[-_WX?_  JQ10!0ANHQ
M-<G;+S(#Q"_]Q?:I_M<?]V;_ +\/_A1;_P#'Q=_]=1_Z M6* *_VN/\ NS?]
M^'_PH^UQ_P!V;_OP_P#A5BB@"JUU'_=F_P"_+_X5R7Q U9K7P;<6UFLOVW4&
M6RMU,;*6:0X.,CKMW5VG6N#U#_B??%G3]/'SVFAVYO)O3SGX0'W PP_&JIKW
MKO9:F-1^[9;O0Z31;>UT?1;+38%E\NUA6('R'^; Y/3N>:TOM<?]V;_OP_\
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M_P"0?!_UR7^56:K6?_(/@_ZY+_*L)]:NF\5V^G6L<1L-SPS2L"6,HC+[5(.
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M&-0JHBA54#H !TIT _?77_74?^@+4JFK\TM67[>2BX4](_GZDRQHJA50 #H
M, 5+116ASA1110 4444 %%%% %>T_P!2W_763_T,U8JO:?ZEO^NLG_H9JQ0
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M'K]GJ&IVZ8;S[&-V:#V<*0-OOU^N>,74BI<MSLC@JLJ;J6M;H]']Q[W7F_Q
M^'<?B98[S2?L]GJB,=[NNU9U/]\J"<CL<'TK3T_QQX)U%C'#KPBDZ&.YGDA8
M'T^<CGZ5ORS:;;VYN[B^$5N,'S7NF5.?<MBMX5'"7-%G%4H-KEE%Z^1C^!O"
MTGA+PR--GNA<3R2M-*R9V!B ,+GG&%'ZT_Q'XLM=!\JSA@DO]6N>+:PM^9)#
MZG^ZOJ3[^E8FJ>)YM4NVT/P1F_O\#SKXRNUM:*>Y8'#-Z*,_C@BMGP[X,L=#
M$EU))/?ZK/S<7\TC"24^G!X7V_G6<YRG)R[]3:%*-&*<UZ+K\^R*.C^$[RXU
M*/Q%XRF6^U5>;>U3FWLAZ(.[?[1_IFNXZ?PU#]DCV_\ +7_O\_\ C1]DC_OS
M?]_G_P :<8I;&<YRF]?^ O0MU7M_]?=_]=1_Z M'V2/^]-_W_?\ QJ"&UC,U
MR-TO$@'$S_W%]Z9)?HJO]DC_ +TW_?\ ?_&C[)'_ 'IO^_[_ .- %BBJ_P!D
MC_O3?]_W_P :/LD?]Z;_ +_O_C0!8HJO]DC_ +TW_?\ ?_&C[)'_ 'IO^_[_
M .- %BBJ_P!DC_O3?]_W_P :/LD?]Z;_ +_O_C0 6G^I;_KK)_Z&:L5GVMK&
MT+$M+_K)!Q,X_C/O5C[)'_>F_P"_[_XT 6**K_9(_P"]-_W_ '_QH^R1_P!Z
M;_O^_P#C0!8HJO\ 9(_[TW_?]_\ &C[)'_>F_P"_[_XT 6**K_9(_P"]-_W_
M '_QH^R1_P!Z;_O^_P#C0!8JO:?ZEO\ KK)_Z&:/LD?]Z;_O^_\ C5>UM8VA
M8EI?]9(.)G'\9]Z -"BJ_P!DC_O3?]_W_P :/LD?]Z;_ +_O_C0!8HJO]DC_
M +TW_?\ ?_&C[)'_ 'IO^_[_ .- %BBJ_P!DC_O3?]_W_P :/LD?]Z;_ +_O
M_C0!8HJO]DC_ +TW_?\ ?_&C[)'_ 'IO^_[_ .- !:?ZEO\ KK)_Z&:L54LA
MMMRHS@22#DY/WS5N@ K@J[VN"H [2S_Y!\'_ %R7^56:K6?_ "#X/^N2_P J
MSYM<M8?$%OHOERR7$R%RR %(N"0&YR"0K8P#]TYQQD V:*P=3UZ/2;R"*XTV
M]:VD>.-[N-4\F%I'V(&RP8Y8C[JMC(SBMZ@"C9_\?FI?]? _]%1U>JC9_P#'
MYJ7_ %\#_P!%1U>H **** "BBB@ HHHH *KV_P#K[O\ ZZC_ - 6K%5[?_7W
M?_74?^@+0!F^(-#L?$6A7.DWRGR;A=I9#@J0001]" ?PK@-!^"^@Z>D_]LS-
MJ[R8"$AH!&/8*^<^^:]5Y]<4ZLW",G=HWAB*M.#IQDTF>1>*O@_%J&GHOA_4
M)H)HWRD-Y</)" >N."5/YU)X;\'^//!VEBWT?4M+O4D<RS6URCJ Q !V..3P
M!U 'M7J_U%!%'LXWYEH:?7*CI^SD[KS1X'XL^*'CG1]>AT^338=*>$*TD+$3
M"XSSD-C[I'&!R.<G/3N(-6^)&O644MGHUAH<$J!O-O)3-)@C.0B@8/LPKL[O
M2-*OKB&:_P!.MKJ6 YB>:%79#U^4D<=.U: *X-)1E=W>A=3$4W"*A!)K=GSU
MJWPK\;:AXS^T3W@O8[AE>34]RQ[/7]WG<,8P ..G3MZWIOP_\(Z6@,.@VK/U
M\R9?-;/KE\XKK.])SZYIQIQBVR:N,J58Q@W9+MI]Y3MX(0US&(U""0+M XQL
M7C%-L=)TS2XGCTW3K6R1VW,MO"L88^I"@9-6;?\ U]U_UU'_ * M3U1R<S[F
M1J&@Z3K SJFFVUX.WG0JY'T)&17EWCOX4K)I\<O@VQ,3B0M-9^<0DN> R[VV
M@CGTX->SD4N.*F<(S5FC>EB:E*2E%[=.AP?PQ\,ZAX7\*?8]48"ZEF:9HU(/
ME9"C;D<'[N>/6N]I*3-4DHI11G4J2J3<Y;L?1115&857M_\ CXN_^NH_] 6K
M%5[?_CXN_P#KJ/\ T!: +%%%% !1110 4444 %%%% %>T_U+?]=9/_0S5BJ]
MI_J6_P"NLG_H9JQ0 4444 %%%% !1110 57M/]2W_763_P!#-6*KVG^I;_KK
M)_Z&: +%%%% !1110 4444 %%%% %>T_U+?]=9/_ $,U8JO:?ZEO^NLG_H9J
MQ0 5P5=[7!4 =I9_\@^#_KDO\JYB3PK>Q^)X-8MM>O3%]J>ZFMI!#L),>P*I
M\K=C  Y;@=.:Z>S_ .0?!_UR7^56: .0U&U\57FK:?(VGZ7)80!)9+<W\B'S
MP>N?(.]5X*CY?FY/08Z^BB@#+MXI'O=1VW$D8\\<*%Q_JH_4&KOD2_\ /[-^
M2?\ Q-06?_'YJ7_7P/\ T5'5Z@"#R)?^?V;\D_\ B:/(E_Y_9OR3_P")J>B@
M"#R)?^?V;\D_^)H\B7_G]F_)/_B:GHH @\B7_G]F_)/_ (FCR)?^?V;\D_\
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M3_ST]Z -.BJ7EZK_ ,_EI_X#-_\ '*/+U7_G\M/_  &;_P".4 7:*I>7JO\
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M5^'X;R&SN[F^MC9S7=W)<?9V96:-3@*&*DKG !."0,XR<9H WZ*** "BBB@
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(_?9JK0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140184771715664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LEXARIA BIOSCIENCE CORP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001348362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  04,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-52138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2000871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">100 &#8211; 740 McCurdy Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Kelowna<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">V1X 2P7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-6424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LEXX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">BC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>lxrp_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrp-20240104.xsd" xlink:type="simple"/>
    <context id="From2024-01-04to2024-01-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
        </entity>
        <period>
            <startDate>2024-01-04</startDate>
            <endDate>2024-01-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-01-04to2024-01-04">0001348362</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-01-04to2024-01-04">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2024-01-04to2024-01-04">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-01-04to2024-01-04">2024-01-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2024-01-04to2024-01-04">LEXARIA BIOSCIENCE CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-04to2024-01-04">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2024-01-04to2024-01-04">000-52138</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-04to2024-01-04">20-2000871</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-04to2024-01-04">100 &#x2013; 740 McCurdy Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-04to2024-01-04">Kelowna</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-04to2024-01-04">BC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="From2024-01-04to2024-01-04">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-04to2024-01-04">V1X 2P7</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-04to2024-01-04">250</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-04to2024-01-04">765-6424</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2024-01-04to2024-01-04">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2024-01-04to2024-01-04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2024-01-04to2024-01-04">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2024-01-04to2024-01-04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2024-01-04to2024-01-04">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-01-04to2024-01-04">LEXX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-01-04to2024-01-04">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-04to2024-01-04">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #VB"18E68+5E\$   ,$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8VW*C.!"&7T7%;,W5)"!\G(SM*H<X.]Z</'$VD]JMO9!!ME4!B14B3MY^
M6]@&3RUN?&,0T+\_6N+OAL%&Z==LS;DA[TDLLZ&S-B:]<-TL7/.$9><JY1+.
M+)5.F(&A7KE9JCF+BJ D=GW/Z[H)$](9#8IC,ST:J-S$0O*9)EF>)$Q_7/)8
M;88.=?8''L5J;>P!=S1(V8K/N?DSG6D8N:5*)!(N,Z$DT7PY=,;TXM+OV(#B
MBF?!-]G!/K&WLE#JU0ZFT=#Q+!&/>6BL!(/-&P]X'%LEX/AW)^J4_VD##_?W
MZM?%S</-+%C& Q7_%)%9#YV^0R*^9'EL'M7F.]_=4 $8JC@K?LEF>VW;<TB8
M9T8ENV @2(3<;MG[+A&' ?1(@+\+\ ON[1\5E%?,L-% JPW1]FI0LSO%K1;1
M ">DG96YT7!60)P9!>J-ZX%K0,H><,-=V.4VS#\2]@>3Y\1K?R&^Y[=_#7>!
MH,3P2PR_T&MA&.3O\2(S&B;JGSJBK4*[7L&NWHLL92$?.K \,Z[?N#/Z_(EV
MO6\(7ZOD:V'JHXDTPGR01[X2EE :<L\27D>)Z]Q.7L:/TS&YG#[,@^GD/IB0
MX.%Q=HX@MDO$]BF( 9< &).IC/@[N>$?=9"XDN=YM-7NM[H^@M4IL3JHV)4*
M<WB*#7GZ2&L3AH?WSVX0B&X)T455QD 0%137,5O54>#Q2Q9G'.'HE1R]4^9H
MDG"]$G)%?H=XLR:!2E(F:V<*UVOBZI=<_=,F:<:U4!&9R(B G=3.%ZY4&$/A
M#$W6\+5D^WI*SJY%S,E]GBSJ[0K7@!5]UO%IJX_P4*^R3.\4HJD,E4Z59D5Y
MF1O(%\QD#H\?/(4JJDU>@_+],P9XX.GT%, G]DZF$4RK6(IP2WD\@0V2OG<&
MA=[K]RA&6-D]1=UZ3SB.(O#JK-S>PF6$UN+A>M3SR.=/?9_2;Z37]LA=&.0Z
M L-6+,* *_^G)Q6 /6A@!P^:/*F-K,7%U6YL-R091E;9/CW)]_=D,Y49L/^_
M1'I\$>*"S_2%^+,>!E>9/\7MN\C3&-K%XS"X@-_Q,)"J %#<P6]5"%F9K97$
M7*1!I-?MG'7;J*O1JA10W+OG/,RU30_U%^1)F+@^/;@(5(ZD,!\5OGXA*=/D
MC<4Y)[]YYU#$20I-5;9F&JL1M"H2%/?V)\TB6[7F'\E"Q;6TN !T/R\82542
M*.[G9>XF[^&:R14_VHXU"-V/YU?C'U@#6U4%_Z2JL'\.M_4 +&*FU9N082U=
M@^1E@)%5Y< _J1R4WK6M4;4\N% PQG@.>GW<K'_"U!DN;=N3Y')7FK):'ERH
MJ?WQ*WOW<4.>JUB$PMC5?0?SI@6K7=\-*HT\E:G[N ?/-"_2PV'A;+MG:&#A
M87Y8+NN=JT&OD:QR=!\WY/^13;,L![)&0%SV**![\&YKOQ/<,=LZ9R3F2Q#R
MSGN@J[>OWMN!46GQNKM0!EZ>B]TU9\!F+X#S2Z7,?F#?H,L/(*/_ %!+ P04
M    " #VB"18GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0
M_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=
M/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M
M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQN
MZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX
M_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)
MWMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBM
MNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,
MX_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*
M'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1
MJP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF
M<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>
M(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>
MN$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM
M0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'
M$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[
M*CG_5U/\!%!+ P04    " #VB"18EXJ[',     3 @  "P   %]R96QS+RYR
M96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY
M/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL
M/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%
MY4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.
MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( /:()%BJQ"(6,P$  "("   /
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /:()%@D'INBK0   /@!   :
M          "  <@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( /:()%AED'F2&0$  ,\#   3              "  :T2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="lxrp_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lxrp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lxrp-20240104.xsd</File>
    <File>lxrp-20240104_cal.xml</File>
    <File>lxrp-20240104_def.xml</File>
    <File>lxrp-20240104_lab.xml</File>
    <File>lxrp-20240104_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="lxrp_8k.htm">lxrp_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lxrp_8k.htm": {
   "nsprefix": "lxrp",
   "nsuri": "http://lxrp.com/20240104",
   "dts": {
    "schema": {
     "local": [
      "lxrp-20240104.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "lxrp-20240104_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lxrp-20240104_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lxrp-20240104_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrp-20240104_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "lxrp_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://lxrp.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-04to2024-01-04",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lxrp_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-04to2024-01-04",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lxrp_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001640334-24-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001640334-24-000007-xbrl.zip
M4$L#!!0    ( /:()%CGMINLB 0  (,6   1    ;'AR<"TR,#(T,#$P-"YX
M<V3-6,MNXS84W1?H/[#:M 6J5YP)&L/)((\9($ F!9)ID5W!T+1-E"95DK*=
MOY]+ZFU+'DG)8K(B?<^Y;UV2F7W<K3G:4*69%!=>'$0>HH+(.1/+"R_5/M:$
M,0]I@\4<<RGHA?=*M??Q\N>?9K_X_O/UXSVZE21=4V'0C:+8T#G:,K-"5O0%
M:T.5[^?H?S([4W023(+HS_+W:ZR!)87C@# N);>@#\D%(E:SHT9Q&)V&)]')
M:0EZD@NSQ8HBK,B*&4I,JC!'<ZK94B!P'&4!3='5KP3=KK!:XT31-18V*'2U
M,4&IZT8FKXHM5P;]1GY'U@RZ\Q\^?477J6:":HV>)$^M*_H/="=(@*XX1X^6
MH=$CU51MZ#Q7I\D*C"#(L-#3';_P5L8DTS#<;K?![D7Q0*HE1!)-PN=[)O[S
M<J2BBT[H60C2 DA2I:!8KR7:(34EP5)NPD)J<S4I*%#1)<:)CXTI60NL7YS^
M7!B"4+&7U$"=<YIFI-T("!KZZ8ZLVI%6TH RL:':M(,S&<#CB1_%_B0N2((N
M;8=UYN<\5)+3,(>5+,R(;K?D1/LI,J\)U:WY<9(&7)M$=>0&)'5HP^GMI' Y
M#I^_W#^Y5O'*7H%V:(/'Y^?GH9,6T -DL[&L^ 6^KE(S2-D1/!/V2R<-_'RO
M2#GX0Y@)&U#6"CW+H*QL7)D*H[KZ-A,V:V+4D9*#M*R&,EW5*T4-S7.C]@@-
M_2 .K=AR(MN*)W'=E&VV#E-.U#1%67O$(&@ 1;K^CC> H(J1DB!%#XX4_AX/
M_&QUOFUD=(^+.ICO5(6TFX#(M9O641R=>J@<+9^E6M_2!4XYN)"*_U/,V8+9
M3Y9R:@^3!J F-E@MJ7G :ZH33.@18S""T0P+(8T[.NP6]DG"Q$*Z#9K9SV-J
M*_45,H3LXN_'NT.5;J;<2#@F/<1@^&3+3$>N9$X73#!G)[)_,?*K<]%'CC$+
M]Z%U#2F<@7^)2[>&TTD#T?EMCX:<F4.Z6 1SDO*!I,J;#D[^4Y&E>N:*Z?)(
M%\A-I:GMM M/LW7"[0QQOZW<@6:3Z1>U^1<"#*!C"HA5?F0JN?SOYR0W7*B
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M_$+-. ^&E[[5@X'5;WF6C^V[45'77OAO"-K]S[%I?Q9F^BZ_ 5!+ P04
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MCW[W[J3#7MRN')7;.V^B=[>(KO;CY@502P,$%     @ ]H@D6/]S]-^3 @
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MQTXJM#XL7TTX=BICP^#08 WG/ZY%G(BY#O^\&!OZ=N+X4!E%N]HPWNZDQE5
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MC7)*#.M5=7QB*H_4OP6FIW#RKW)7_P-02P,$%     @ ]H@D6".Q2'Z6!
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M>80'A&M%P$:"G9#O9\:Z%0#Z^$I[<C[CT45WM+_.15>RWZUUKL>KZF463B,
MCQ F3J&EP4K7XJ1A37C3)ASSYABF:Q9*<8_MH V_9O?4HPN6U>QZF@@PEM/^
M>L64T;$9]M_7_%URGT$;'29-@L;:+SJEH]GI2(7Q]Z1L9E+:=-A(4F.N65CI
M#!5MJPBS='3HK+!BON*!UNE/C"$@0A(!"%N2/P%@*X_'$'R]8!?<%\^:I/=9
M;=FH:JY3OC4Q&'"%.Z4$%S")]>/['&NCV2+U0>B+$6C2>I5G>M'%P[P6^961
MS@RR-X]=.N#^J+(8;51L7(PQ(_*= IKRFIW""]O><\^33*GDUV<(<)U<U;%M
M\O-/1T7'.2&'99M<N;5(>B/2%-2;M<1[ST]'3?6D!G_>R+9X +3TB?GP>PXN
MO31+8[YOY"W@-(Z;\]4/M5F6+SW(&#3. \9D"SJ%BS4:+("+9 5HXJP9 CP9
MF[S-]7$K ,K[?_#0X/SJ;\X74KP]?-VH).DZAKBA!,7F(?4)&S(WTOP>(U^P
M_$Q]GUX49HK@5&TZ:M]HIG.2Q3'&^O!$ 9G/PKX(& D,1MI#>.A'Z.8(E8S"
M.O#8-V<\=Y^]F-"JGP/_>/D4]^W9I?/^^1;VLW"I?XN#3^.'PX-]ZZ"\I53I
MAK<W5IO)N"]___S[Y]OZ2<8YF7CAKG,M[5X"*(/@*\X/2X/1X)'&[A0L:I?$
M^V8 >1 O$I^J=#\I_WZ-JWTV)?QBX>'2S>D)QUJ?N7=F Y&&H10 *##ET1%#
MTD&0CD+!0A0=.;(^D2[WT>=P!0Y(,S! 'NY+*CZ(?$T#)B+ECX@"^Z2Z(U,S
MJ2 ZP-B8K73#,I.>-X:,T&"4EG6%#\RQ'B99.68(5&4]4?/S\O$8E3X2NV9.
MTCPC,DT ]J;V4R82>;;K_EUR#5J">9XH2/(1:CXZPA.''0I3#B(QB83CPW+Y
M9-Z[SP<EFY9(,B 0179$),SLT3<C4)UR<3_1ZIF]>=R2WW4.2>VR28HE.P^$
MLUCVZPKQYO2@!8&B"P((>E=@7L#&^&]9"2:C(8-D./,:X)2IY10S2C!U*F.L
M F4['U/^ %IP*QE: CS#:TXIH?N0-]TN0/HWK TP*LO-#.NKML$I>U9QM_-^
M-=V(:7\\[6@H%3'YP^I(B5GE77<U'4EH-YG?7Z-QG?C*&"$R"1@S7'0(SBRB
M!#&"4"JO!1_.R/=E0. *6\,S6MT16HO!1I*R;?Q:*#Z,Y_:)"X&3>N/;[%N4
MI:0FK;?I4^*C04?XNY@W_GOBGB3!Z^3<F5D#++768*@>^AS>3*S9$X[9;=1O
M34;V;-P?&_.14^P8$Y&KHHL'D;2T<._V2$@EN:=^Q,@_[;QM.R3$#[#P4YN%
M7GQM _V=2DQ$*'0OMY&$J5.,9+NZM<V4MSKSB16+K8HYB/IELU.*''__T::M
M#4CHQ19M"CC-4>(Y\(T&;GSZD2J/_C6WG5VC(=<0&U]1><?T>J<;1QYW8Q';
M[^S[L@F31N!A$,'PHVS7I'(!L=^!QV'FQ-I,GI4K0@,"$0B"^A[I2?&@^QB+
MA)A[I8IXK,N#^(ATG,:R]Q=\7S+YK*1$=G&8AR<FE942<W.X.L3#U9AGCP.:
M8L<JKOBMRKA1#&XF]3+-YM<B5G.B"(1:7RR@9$)?YOQ!RN.C85&+.3PKQ%V7
M-#:CQ]U'-!,WNQ>J.9_;20#'39@/ 2(H<2!,N!B!*T<J8)OL5^"M)MR$D/$W
MTRAUP\L?(?,'#JQQ0> (H$2R>ZZ@'BP-&KB8[*.N.<^#Q'COAT>EI^*="F]9
MK%K:I>-8-:OS>3*>TZT$K\_\\G?)5[Q/^5IXUC)_/<9>RYZ+"5[A?=CIRXG8
MO@&CM^M?VE;C^J)^W8XG)+<:QI_,_DY(>\SJ2$;O+-H%>U<AU'^@([7S#0>0
MYGK^G7F^-.IJ:#8@AWG;&4=5"?ODJ<EZD1]O/%Y>D NN7%_@M_NSY&_V0]$)
MDYN S'Q+N$<^LR&5G)(/7"B78_X1XAH9YM'''A6+$SDEA!FQ0+%S\AXL80#&
MSD7#:;9S S" DJG(AW"I"WTS'U/U(^@C"3DX*AA>Y(W(+E+/\&AAR3R'.#YF
M& B:"V8HN6#]D2=INU[[!:C*1\43-*\N4VB'/:%HCZ7&M.='+NV)P/+Y'0.#
M'FHPPI8S-[Z/GV\M9YZW)R,PXFQ H1VL";X@"F( -.HP7T4*INZP?$)HC^(M
M3] Y"%K!(S,_TQ&\&BG3YTQGIUO))SE41*M&&.0!'!9@""\R+@O84A(%W-P?
MID<H9T8EIM0,SD6(1HDKA5*6 !K :PI4@)B_]8-(1(\;YEKM$3PN!BU>0S&>
MFX*9C.<0@(6(QWC!7!8?)P/$*!EX5Q@9E-^S@/09]75_1%34^1.\F"(/0(%C
MAGX:%VGR'!J_O*48Y/AL/:ALPXNHF55M/9ZG,0*AVLC(.28=7P!V" 4'5Z\H
MWFQC^,5O0/RZ#[380E8SC!HF5;-JYX/,?:,-?3#D!KK#@L+:,WJ(@%,*/^48
MSRDP"L%;Q*V8DZ'9MF&B8X9F!LNE=RD/'BSIGV'.5^#_MJ9\^CS,M*->>D+F
M'. #NH^,V4N5(1;]J]EWV-JYE&Q*XUF;2\M3SMLX_3+WP78R#I4DM:#/1Z6I
MLVM;WF8<FVH)=IW?8WRR>'U/_%/63G@\#IK8$.,B@Q6,N\ RUNV:EL&T#(2'
M%R@QB&DAMJ+&!(W?>9Q*":YC8OW&G=+T+NW1XS9MPM_;XH'[A0OP97.)4Q:H
MM(4.K,3M54E^:\<;WIPQF%_UD@',Q L<#1A X"PP-R*(+P 9I.#A&X 'PI5!
M!"AP(&1J(O 3%%CY T#+&O[ABH>:"K>^ NV/EG0BX6V IPEY 5V:_ H=9UC
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M   1              "  0    !L>')P+3(P,C0P,3 T+GAS9%!+ 0(4 Q0
M   ( /:()%B/U6(_VP$  (L#   5              "  ;<$  !L>')P+3(P
M,C0P,3 T7V-A;"YX;6Q02P$"% ,4    " #VB"18_W/TWY,"  !$"   %0
M            @ '%!@  ;'AR<"TR,#(T,#$P-%]D968N>&UL4$L! A0#%
M  @ ]H@D6+H(^[(K!@  @SD  !4              ( !BPD  &QX<G M,C R
M-# Q,#1?;&%B+GAM;%!+ 0(4 Q0    ( /:()%@CL4A^E@0  &4D   5
M          "  >D/  !L>')P+3(P,C0P,3 T7W!R92YX;6Q02P$"% ,4
M" #VB"18PO#U^FD0  !.;   "P              @ &R%   ;'AR<%\X:RYH
M=&U02P$"% ,4    " #VB"18<'K!\(85  !NCP  #@              @ %$
G)0  ;'AR<%]E>#DY,2YH=&U02P4&      < !P#  0  ]CH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
